RE:NBOC increases their holding by 117 per cent
"To us, the main question is why continue to invest in the development of such risky assets when time, bandwidth and cash could, perhaps, be invested in other assets with, potentially, better visibility and/or ROI such as, possibly, TH's commercial platform."
This is what National bank’s analyst said on December second day after the pause announcement, not very optimistic about company’s decision regarding amending the trial/submitting it…as per the PR day before. As of 10/13 they had about 240k shares worth $561k average SP at $2.3 then they added (521-240) 281k shares by the end of calendar year 2022 with the total value $462k, their 521k shares have an average SP at $0.88, THTX year low SP was $0.77 so they must have picked those shares after the pause after their brilliant skeptical analysis. Correct me if I am wrong looking at those numbers the pessimistic National bank must have picked up those shares at near multi year lows before that letter from Paul which National bank analyst was a big fan of. Naturally if “investing in the development of such risky assets…” is the wrong approach why increasing their portfolio by 117 per cent and that was before the announcement of planning for positive EBIDTA/cash flow, stage wise decisions about oncology considering the costs etc.
Point is relying on these analysts which time after time have been proven to be dishonest is absolute waste of time, no wonder with PTs from $3 to $9 we don’t have a long line up of investor in hurry to have a piece of this great investment opportunity. THTX for you commercial products your strategy has been direct to patient/doctors approach attending HIV seminars, arranging educational meetings for HIV communities, Thera Thursdays etc. etc. how about implementing the same communication strategy for the investment communities! DIRECT TO INVESTOR APPROACH...